Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07693569 · ClinicalTrials.gov registry record · Early Phase 1
Collagenase Injection for Spasticity Management
A Early Phase 1 study, sponsored by The University of Texas Health Science Center, Houston.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 15
- Enrollment target
NCT07693569 is a Early Phase 1 study that has not yet begun recruiting, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 15 participants.
The verdict
NCT07693569, a Early Phase 1 study, has not yet begun recruiting, sponsored by The University of Texas Health Science Center, Houston.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
The overall goal is to investigate the effectiveness of a novel intervention - Collagenase injection, for spasticity management in patients with neurological impairments, such as stroke, brain injury, and spinal cord injury.
Interventions
- BIOLOGICAL XIAFLEX Collagenase injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2031-09-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07693569
The ClinicalTrials.gov registry entry for NCT07693569 describes a study currently listed as not yet recruiting, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which XIAFLEX Collagenase injection is the first listed.
NCT07693569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07693569 about?
NCT07693569 is a clinical study titled "Collagenase Injection for Spasticity Management". The overall goal is to investigate the effectiveness of a novel intervention - Collagenase injection, for spasticity management in patients with neurological impairments, such as stroke, brain injury, and spinal cord injury.
What is the current status of trial NCT07693569?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2026-09-01. Estimated completion is 2031-09-30.
What interventions are being tested in trial NCT07693569?
The interventions under investigation include: XIAFLEX Collagenase injection (BIOLOGICAL).
Who is sponsoring clinical trial NCT07693569?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.